SEC Stock Data Quick Answer cbdMD, Inc. reported Stockholders Equity of $7.23 million for fiscal year 2025. cbdMD, Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $7.23M +268.0% 2024 $1.96M -35.2% 2024 $3.03M -1.9% 2024 $3.09M -56.1% 2023 $7.04M -22.1% 2023 $9.03M -64.9% 2023 $25.73M -0.2% 2023 $25.79M -3.0% 2022 $26.59M -15.4% 2022 … Read more
Quick Answer cbdMD, Inc. reported Long-Term Debt of $9.00 for fiscal year 2023. cbdMD, Inc. Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2023 $9.00 -100.0% 2022 $125.5K +15.1% 2021 $109.0K -58.8% 2020 $264.4K — Quarterly Long-Term Debt Quarter Ending Long-Term Debt YoY QoQ December 31, 2023 $0.00 — -100.0% September 30, … Read more
Quick Answer cbdMD, Inc. reported Cash and Equivalents of $2.26 million for fiscal year 2025. cbdMD, Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $2.26M -7.8% 2024 $2.45M +36.4% 2023 $1.80M -73.2% 2022 $6.72M -74.6% 2021 $26.41M +78.2% 2020 $14.82M +216.1% 2019 $4.69M +9.5% 2018 $4.28M +1406.6% 2017 … Read more
Quick Answer cbdMD, Inc. reported Total Assets of $10.42 million for fiscal year 2025. cbdMD, Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $10.42M -1.5% 2024 $10.58M -34.7% 2023 $16.20M -60.3% 2022 $40.79M -67.3% 2021 $124.88M +12.7% 2020 $110.84M +17.3% 2019 $94.52M +529.4% 2018 $15.02M +112.4% 2017 $7.07M +335.5% 2016 … Read more
Quick Answer cbdMD, Inc. reported Diluted EPS of $13.32 per share (loss) for fiscal year 2023. cbdMD, Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2023 -$13.32 +76.1% 2022 -$55.80 -11772.3% 2021 -$0.47 -267.9% 2020 $0.28 — 2019 $0.00 — 2018 $0.00 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY … Read more
Quick Answer cbdMD, Inc. reported Net Income of -$2.04 million for fiscal year 2025. cbdMD, Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$2.04M +44.8% 2024 -$3.70M +83.9% 2023 -$22.94M +67.3% 2022 -$70.08M -199.6% 2021 -$23.39M -285.6% 2020 $12.60M +124.5% 2019 -$51.36M -81835.3% 2018 $62.8K +104.5% 2017 -$1.39M +64.4% 2016 … Read more
Quick Answer cbdMD, Inc. reported Total Revenue of $19.19 million for fiscal year 2025. cbdMD, Inc. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $19.19M -1.5% 2024 $19.48M -19.3% 2023 $24.16M -31.8% 2022 $35.40M -20.4% 2021 $44.48M +6.2% 2020 $41.88M +77.1% 2019 $23.65M +5051.8% 2018 $459.1K -89.7% 2017 $4.47M +120.3% 2016 … Read more
Quick Answer cbdMD, Inc. reported Total Revenue of $19.19 million for fiscal year 2025. cbdMD, Inc. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $19.19M-1.5% $19.48M-19.3% $24.16M-31.8% $35.40M-20.4% $44.48M+6.2% $41.88M+77.1% Net Income -$2.04M+44.8% -$3.70M+83.9% -$22.94M+67.3% -$70.08M-199.6% -$23.39M-285.6% $12.60M+124.5% Diluted EPS — — -$13.32+76.1% -$55.80-11772.3% -$0.47-267.9% $0.28 Total Assets $10.42M-1.5% … Read more
Quick Answer Yubo International Biotech Ltd reported Gross Profit of $8.2 thousand for fiscal year 2025. Yubo International Biotech Ltd Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $8.2K +208.3% 2024 $2.6K -99.4% 2023 $419.2K +696.1% 2022 $52.7K -93.6% 2021 $820.6K -33.8% 2020 $1.24M — Quarterly Gross Profit Quarter Ending Gross … Read more
Quick Answer Yubo International Biotech Ltd reported Operating Income of -$1.19 million for fiscal year 2025. Yubo International Biotech Ltd Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$1.19M +32.9% 2024 -$1.77M -48.1% 2023 -$1.19M +0.9% 2022 -$1.21M +21.9% 2021 -$1.54M -116.8% 2020 -$711.8K -2354.5% 2020 -$29.0K +39.6% 2019 -$48.0K +17.2% … Read more